{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:30:45Z","timestamp":1793327445299,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.canlet.2026.218884","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:25:23Z","timestamp":1792020323000},"page":"218884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MDK+ cancer-associated fibroblasts promote immunotherapy resistance through mitochondrial reprogramming in breast cancer"],"prefix":"10.1016","volume":"662","author":[{"given":"Wei","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhou","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajie","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zikun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib1","first-page":"10","article-title":"Cancer statistics","volume":"75","author":"Siegel","year":"2025","journal-title":"CA: Cancer J. Clinic. 2025"},{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12943-024-01990-4","article-title":"Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer","volume":"23","author":"Kundu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.canlet.2026.218884_bib3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1515\/jtim-2024-0038","article-title":"Intratumoral microbiota in orchestrating cancer immunotherapy response","volume":"12","author":"Zou","year":"2024","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.canlet.2026.218884_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218227","article-title":"Histone lactylation bridges metabolic reprogramming with chromatin-immune crosstalk in triple-negative breast cancer","volume":"639","author":"Li","year":"2026","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib5","article-title":"Mitochondria and tumorigenesis: molecular basis and therapeutic implications","volume":"13","author":"Huang","year":"2026","journal-title":"Genes Dis."},{"key":"10.1016\/j.canlet.2026.218884_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101126","article-title":"crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer","volume":"77","author":"Zou","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2026.218884_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218328","article-title":"Targeting the SIN1 mediated TTK\/LDHA-H3K18la-GLUT3 axis disrupts metabolic-epigenetic crosstalk and suppresses progression in hyperglycolytic breast cancer","volume":"644","author":"Zhao","year":"2026","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12935-024-03327-z","article-title":"Spatial and single-cell explorations uncover prognostic significance and immunological functions of mitochondrial calcium uniporter in breast cancer","volume":"24","author":"Li","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.canlet.2026.218884_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-014134","article-title":"Targeting the neuro-immune crosstalk in breast cancer brain metastases","volume":"14","author":"Zou","year":"2026","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2026.218884_bib10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2183\/pjab.86.410","article-title":"Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases","volume":"86","author":"Muramatsu","year":"2010","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"15","key":"10.1016\/j.canlet.2026.218884_bib11","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1111\/febs.14828","article-title":"Structures and interactions of syndecans","volume":"286","author":"Gondelaud","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.canlet.2026.218884_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-017-0621-z","article-title":"Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6\/STAT3, Notch and EGFR signaling pathways","volume":"16","author":"Ibrahim","year":"2017","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2026.218884_bib13","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/1097-0142(19940901)74:5<1584::AID-CNCR2820740514>3.0.CO;2-V","article-title":"Midkine and pleiotrophin expression in normal and malignant breast tissue","volume":"74","author":"Garver","year":"1994","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.canlet.2026.218884_bib14","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.1007\/s13277-015-3710-x","article-title":"The clinical and prognostic significance of midkine in breast cancer patients","volume":"36","author":"Li","year":"2015","journal-title":"Tumour Biol."},{"issue":"11","key":"10.1016\/j.canlet.2026.218884_bib15","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41419-021-04102-y","article-title":"USP12 promotes breast cancer angiogenesis by maintaining midkine stability","volume":"12","author":"Sheng","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218884_bib16","article-title":"Targeting MDK abrogates IFN\u03b3-elicited metastasis in cancers of various origins","volume":"12","author":"Zheng","year":"2022","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218884_bib17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41588-019-0554-0","article-title":"ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer","volume":"52","author":"Xu","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218884_bib18","article-title":"ERCC1 is a potential biomarker for predicting prognosis, immunotherapy, chemotherapy efficacy, and expression validation in HER2 over-expressing breast cancer","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218884_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218105","article-title":"Neutrophils exposed to a cholesterol metabolite secrete extracellular vesicles that promote epithelial-mesenchymal transition and stemness in breast cancer cells","volume":"636","author":"Krawczynska","year":"2026","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/jtim-2025-0005","article-title":"Senescent cells as a target for anti-aging interventions: from senolytics to immune therapies","volume":"13","author":"Fu","year":"2025","journal-title":"J. Transl. Int. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1515\/jtim-2025-0051","article-title":"Focal adhesion kinase inhibition enhances response to checkpoint immunotherapy in hepatocellular carcinoma","volume":"14","author":"Liu","year":"2026","journal-title":"J. Transl. Int. Med."},{"issue":"3","key":"10.1016\/j.canlet.2026.218884_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.32604\/or.2024.054642","article-title":"Ultrasound genomics related mitochondrial gene signature for prognosis and neoadjuvant chemotherapy resistance in triple negative breast cancer","volume":"33","author":"Huang","year":"2025","journal-title":"Oncol. Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41580-020-00300-2","article-title":"Quality control of the mitochondrial proteome","volume":"22","author":"Song","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218884_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1146\/annurev-immunol-110519-071134","article-title":"Insights gained from single-cell analysis of immune cells in the tumor microenvironment","volume":"39","author":"Ren","year":"2021","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12929-023-00925-3","article-title":"The biology of SCUBE","volume":"30","author":"Lin","year":"2023","journal-title":"J. Biomed. Sci."},{"issue":"2\u20133","key":"10.1016\/j.canlet.2026.218884_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.mam.2013.01.002","article-title":"Mammalian iron transporters: families SLC11 and SLC40","volume":"34","author":"Montalbetti","year":"2013","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.canlet.2026.218884_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215834","article-title":"Single cell RNA-seq reveals the CCL5\/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer","volume":"545","author":"Chen","year":"2022","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152756","article-title":"Relationship between SDC1 and cadherin signalling activation in cancer","volume":"216","author":"Liao","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib30","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13046-025-03432-5","article-title":"Deciphering the tumor immune microenvironment: single-cell and spatial transcriptomic insights into cervical cancer fibroblasts","volume":"44","author":"Lin","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2026.218884_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.32604\/or.2023.043926","article-title":"The anti-neoplastic effects of metformin modulate the acquired phenotype of fibroblast cells in the breast cancer-normal fibroblast co-culture system","volume":"32","author":"Mostafavi","year":"2024","journal-title":"Oncol. Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib32","article-title":"Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"issue":"Pt 17","key":"10.1016\/j.canlet.2026.218884_bib33","first-page":"3799","article-title":"Syndecan-4 signaling at a glance","volume":"126","author":"Elfenbein","year":"2013","journal-title":"J. Cell Sci."},{"issue":"6","key":"10.1016\/j.canlet.2026.218884_bib34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","article-title":"The broken cycle: E2F dysfunction in cancer","volume":"19","author":"Kent","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2026.218884_bib35","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1093\/carcin\/bgt208","article-title":"Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis","volume":"34","author":"Clarke","year":"2013","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib36","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1038\/s41598-022-08210-3","article-title":"Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors","volume":"12","author":"Dalal","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib37","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1038\/s41467-021-25962-0","article-title":"Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer","volume":"12","author":"Hammerl","year":"2021","journal-title":"Nat. Commun."},{"issue":"7693","key":"10.1016\/j.canlet.2026.218884_bib38","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib39","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","article-title":"DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load","volume":"10","author":"Jung","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2026.218884_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.canlet.2026.218884_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.canlet.2026.218884_bib42","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1096\/fj.201700740R","article-title":"Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy","volume":"32","author":"Wang","year":"2018","journal-title":"FASEB J."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:36:06Z","timestamp":1793324166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526006488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":42,"alternative-id":["S0304383526006488"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218884","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MDK+ cancer-associated fibroblasts promote immunotherapy resistance through mitochondrial reprogramming in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218884"}}